- Home
- CBFV vs UNCY Comparison
CBFV vs UNCY Comparison
Compare CBFV & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBFV | UNCY |
|---|---|---|
| Founded | 1901 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.5M | 141.8M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CBFV | UNCY |
|---|---|---|
| Price | $33.76 | $6.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $38.00 | ★ $44.50 |
| AVG Volume (30 Days) | 3.3K | ★ 430.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | N/A | ★ 56.25 |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $43,557,000.00 | $675,000.00 |
| Revenue This Year | $12.14 | N/A |
| Revenue Next Year | $14.00 | N/A |
| P/E Ratio | $1,131.67 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.03 | $0.45 |
| 52 Week High | $37.75 | $7.57 |
Technical Indicators
Market Signals| Indicator | CBFV | UNCY |
|---|---|---|
| Relative Strength Index (RSI) | 40.40 | 52.42 |
| Support Level | $32.03 | $6.48 |
| Resistance Level | $34.09 | $7.36 |
| Average True Range (ATR) | 0.45 | 0.35 |
| MACD | -0.11 | 0.00 |
| Stochastic Oscillator | 16.44 | 48.86 |
Price Performance
Historical ComparisonAbout CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.